#9450
Strongyloïdes
ratti IgG ELISA
ELISA kit for the diagnosis of human strongyloidosis
Lot 2316S (Expiry date : 31.12.2024)
Production date : 01.05.2023
Results of quality control 2 (after
6 months), date: 27.10.2023
No serum blank (average) : 0.116
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.005 |
-0.003 |
0.002 |
0.006 |
0.000 |
0 |
Negative control serum
(N° 9450-06) |
0.092 |
0.112 |
0.110 |
0.137 |
0.112 |
5 |
Weak positive serum
(N° 9450-07) |
0.813 |
0.876 |
0.870 |
0.885 |
0.861 |
36 |
Positive control serum
(N° 9450-08) |
2.211 |
2.450 |
2.336 |
2.565 |
2.390 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 9450-08 |
> 1.200 |
2.390 |
Yes |
Absorbance of weak positive serum 9450-07, as % of positive
serum |
> 18 % |
36 % |
Yes |
Absorbance of negative serum 9450-06, as % of positive serum |
< 10 % |
5 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.116 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bâtiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|